Germany

Nocturne GmbH

2020 Science Start-ups

Nocturne provides products and services to improve the diagnostic and monitoring of neurological disorders through imaging of the eye, based on state-of-the-art AI analysis. Currently, our main focus is multiple sclerosis, with future applications in Parkinson’s and Alzheimer’s disease. Our software solution is flexible, easy to use and integrate into the hospital environment. It was developed in close collaboration with lead neurologist in this field during more than 6 years of research. It uses a non-invasive, fast and cost-efficient widely available hardware, that provides physicians quantifiable, fast measurements to further make the optimal therapy decisions. By combining existing and established hardware on the market, Nocturne expects that its retinal image analysis will allow neurologists short-term diagnostic decisions, which will reduce the need for external costly tests like MRIs. Ultimate goal is to offer specialized screening analysis for early detection of these diseases.

Content by this speaker